anti-Cytochrome P450, Family 2, Subfamily C, Polypeptide 9 (CYP2C9) Antikörper

CYP2C9 encodes a member of the cytochrome P450 superfamily of enzymes. Zusätzlich bieten wir Ihnen CYP2C9 Kits (22) und CYP2C9 Proteine (4) und viele weitere Produktgruppen zu diesem Protein an.

Alle Antikörper anzeigen Gen GeneID UniProt
CYP2C9 1559 P11712
CYP2C9    
CYP2C9    
Direkt bei antikoerper-online bestellen
  • +49 (0)241 95 163 153
  • +49 (0)241 95 163 155
  • Online bestellen
  • orders@antikoerper-online.de

Top anti-CYP2C9 Antikörper auf antikoerper-online.de

Showing 10 out of 58 products:

Katalog Nr. Reaktivität Wirt Konjugat Applikation Bilder Menge Anbieter Lieferzeit Preis Details
Rind (Kuh) Kaninchen Unkonjugiert WB <b>WB Suggested Anti-CYP2C9 Antibody Titration: </b>0.2-1 ug/ml<br><b>Positive Control: </b>Jurkat cell lysate 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
358,51 €
Details
Human Kaninchen Unkonjugiert EIA, IHC (p), WB 0.4 mL Anmelden zum Anzeigen 7 bis 9 Tage
407,00 €
Details
Human Kaninchen Unkonjugiert WB Western blot analysis of Cytochrome P450 2C9 expression in HeLa (A), Raw264.7 (B), PC12 (C) whole cell lysates. 200 μL Anmelden zum Anzeigen 11 bis 13 Tage
464,29 €
Details
Human Kaninchen Unkonjugiert EIA, WB 0.4 mL Anmelden zum Anzeigen 7 bis 9 Tage
407,00 €
Details
Human Maus Unkonjugiert WB CYP2C9 Antibody (N-term) (Ascites) (ABIN1882233) western blot analysis in NCI-H460 cell line lysates (35 µg/lane). This demonstrates the CYP2C9 antibody detected the CYP2C9 protein (arrow). 0.1 mL Anmelden zum Anzeigen 14 bis 16 Tage
335,24 €
Details
Pferd Kaninchen Unkonjugiert WB 50 μg Anmelden zum Anzeigen 11 bis 14 Tage
653,02 €
Details
Human Maus Unkonjugiert FACS, IHC (p), WB 100 μL Anmelden zum Anzeigen 11 bis 14 Tage
583,17 €
Details
Human Kaninchen Unkonjugiert IHC (p), WB Western blot analysis of anti-CYP2C9 Antibody (Center)(ABIN392364) in CEM cell line lysates (35 µg/lane).CYP2C9(arrow) was detected using the purified polyclonal antibody. Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with CYP2C9 antibody (Center), which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL Anmelden zum Anzeigen 14 bis 16 Tage
335,24 €
Details
Human Kaninchen Unkonjugiert IHC (p), WB Western blot analysis of anti-CYP2C9 Antibody (N-term) (ABIN392355) in Jurkat cell line lysates (35 µg/lane). CYP2C9(arrow) was detected using the purified polyclonal antibody. 400 μL Anmelden zum Anzeigen 14 bis 16 Tage
335,24 €
Details
Human Maus Unkonjugiert FACS, IHC, WB HEK293T cells transfected with either RC220997 overexpress plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-CYP2C9 antibody (ABIN2455183), and then analyzed by flow cytometry. HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CYP2C9 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 µg per lane) were separated by SDS-PAGE and immunoblotted with anti-CYP2C9. 100 μL Anmelden zum Anzeigen 6 bis 8 Tage
366,67 €
Details

CYP2C9 Antikörper nach Reaktivität, Anwendung, Klonalität and Konjugat

Attribute Applikationen Wirt Klonalität
Human , , ,
,
,
Mouse (Murine) ,


Rat (Rattus) ,


Am meisten referenzierte anti-CYP2C9 Antikörper

  1. Human Polyclonal CYP2C9 Primary Antibody für Func, IHC (fro) - ABIN2473172 : Gilhodes, Gurfinkel, Roll: Role of Ia muscle spindle afferents in post-contraction and post-vibration motor effect genesis. in Neuroscience letters 1992 (PubMed)
    Show all 4 Pubmed References

  2. Human Monoclonal CYP2C9 Primary Antibody für WB - ABIN1882233 : Yang, Cui, Hasi, Jia, Gong, Su: Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China. in Genetics and molecular research : GMR 2010 (PubMed)
    Show all 3 Pubmed References

Weitere Antikörper gegen CYP2C9 Interaktionspartner

Human Cytochrome P450, Family 2, Subfamily C, Polypeptide 9 (CYP2C9) Interaktionspartner

  1. SNP rs4918758 of CYP2C9 showed a suggestive association with decreased risk of coronary heart disease.

  2. CYP2C9*31075AC genotype with combined alcohol and nevirapine usage indicated a risk for development of antiretroviral-associated hepatotoxicity

  3. CYP2C9 polymorphisms showed no effect on PC doses. Similar findings were observed in the initiation phase of PC therapy. High complications rates under PC therapy were observed particularly at the beginning.

  4. Genetic variants of CYP2C9/VKORC1 (zeige VKORC1 Antikörper) and age are significant determinants of the maintenance dose of warfarin in patients with atrial fibrillation/valve replacement.

  5. CYP2C9*3 polymorphism genotype and allele frequency were not statistically different between the case and control Ankylosing Spondylitis groups (P>0.05). the efficacy of NSAID in treatment of AS and COX-2 (zeige COX2 Antikörper) gene -1290A/G and -1195G/A polymorphism were associated (all P<0.05), but it is not associated with CYP2C9 *3 polymorphism (all P>0.05).

  6. polymorphisms c.98T>C in the UGT1A9 (zeige UGT1A9 Antikörper) and c.1075A>C in the CYP2C9 genes did not affect the pharmacokinetic profile of propofol

  7. Possession of CYP2C9*2 and/or CYP2C9*3 allele variants is associated with lower time of international normalized ratio (INR (zeige INSR Antikörper)) in the therapeutic range (TTR (zeige TTR Antikörper)) values and warfarin dose variations in aortic valve replacement patients, the latter affected also by VKORC1 (zeige VKORC1 Antikörper) c.-1693G>A polymorphism

  8. Three SNPs (CYP2C9 *2, *3 and VKORC1 (zeige VKORC1 Antikörper) c.-1639G > A) were genotyped by electrochemical detection using a sandwich-type format that included a 3' short thiol capture probe and a 5' ferrocene-labeled signal probe.

  9. This study was aimed to describe the distribution of CYP2C9 and CYP2C19 (zeige CYP2C19 Antikörper) alleles and haplotypes in four Mestizo populations from Western Mexico. Frequencies ranged from 2.2-3.0% and 4.8-8.9% for CYP2C9*3 and CYP2C9*2 alleles, respectively, and 5.4-12.0% for CYP2C19 (zeige CYP2C19 Antikörper)*2, whereas the CYP2C19 (zeige CYP2C19 Antikörper)*3 allele was not found.

  10. CYP2C9 IVS8-109 T carriers showed significantly higher dose-corrected phenoytoin blood concentrations and this allele was found in a higher frequency in epileptic patients with supratherapeutic phenytoin levels.

CYP2C9 Antigen-Profil

Protein Überblick

This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by rifampin. The enzyme is known to metabolize many xenobiotics, including phenytoin, tolbutamide, ibuprofen and S-warfarin. Studies identifying individuals who are poor metabolizers of phenytoin and tolbutamide suggest that this gene is polymorphic. The gene is located within a cluster of cytochrome P450 genes on chromosome 10q24.

Genbezeichner und Symbole assoziert mit CYP2C9

  • cytochrome P450, family 2, subfamily C, polypeptide 9 (CYP2C9) Antikörper
  • CPC9 Antikörper
  • CYP2C Antikörper
  • CYP2C10 Antikörper
  • CYPIIC9 Antikörper
  • P450IIC9 Antikörper

Bezeichner auf Proteinebene für CYP2C9

cytochrome P-450 S-mephenytoin 4-hydroxylase , cytochrome P-450MP , cytochrome P450 2C9 , cytochrome P450 PB-1 , flavoprotein-linked monooxygenase , microsomal monooxygenase , xenobiotic monooxygenase

GENE ID SPEZIES
1559 Homo sapiens
Ausgewählte Anbieter für anti-CYP2C9 (CYP2C9) Antikörper
Haben Sie etwas anderes gesucht?